934 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
When Will ImmunoGen, Inc. Finally Start Making Money? https://www.fool.com/investing/2017/04/27/when-will-immunogen-inc-finally-start-making-money.aspx?source=iedfolrf0000001 Apr 27, 2017 - ImmunoGen shareholders have suffered losses for decades. Where is the light at the end of this tunnel?
What's in Store for Merck (MRK) this Earnings Season? http://www.zacks.com/stock/news/258000/whats-in-store-for-merck-mrk-this-earnings-season?cid=CS-ZC-FT-258000 Apr 26, 2017 - Merck & Co., Inc. (MRK) will be reporting first-quarter 2017 earnings on May 2, before market opens. Last quarter, the company delivered a positive earnings surprise of 1.14%.
Tesaro Inc Bulls Need a Reality Check https://www.fool.com/investing/2017/04/25/tesaro-inc-bulls-need-a-reality-check.aspx?source=iedfolrf0000001 Apr 25, 2017 - Has the market overestimated the odds of success for Tesaro's fancy new cancer drug?
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store? http://www.zacks.com/stock/news/257780/bristol-myers-bmy-to-post-q1-earnings-whats-in-store?cid=CS-ZC-FT-257780 Apr 25, 2017 - Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.
Bleak Outlook for Big Drug Makers https://www.wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153?mod=rss_markets_main Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
Better Buy: Celgene Corporation vs. Merck & Co., Inc. https://www.fool.com/investing/2017/04/25/better-buy-celgene-corporation-vs-merck-co-inc.aspx?source=iedfolrf0000001 Apr 25, 2017 - Which drug stock wins in a head-to-head matchup between Celgene and Merck?
America's 12 Most Charitable Companies https://www.fool.com/investing/2017/04/25/americas-12-most-charitable-companies.aspx?source=iedfolrf0000001 Apr 25, 2017 - These healthcare, bank, and tech companies are leading the way in investing in global change.
Vaunted Ebola Vaccine Faces Questions https://www.wsj.com/articles/vaunted-ebola-vaccine-faces-questions-1493072473?mod=pls_whats_news_us_business_f Apr 24, 2017 - The deadly Ebola outbreak in West Africa two years ago, the worst in recorded history, led to a vaccine that seemingly would stop the next Ebola epidemic in its tracks. Now there are questions about that claim.
3 IPOs to Watch For This Week http://www.zacks.com/stock/news/257555/3-ipos-to-watch-for-this-week?cid=CS-ZC-FT-257555 Apr 24, 2017 - The last week of April is scheduled to see eight different companies go public, and Zacks has you covered with three unique IPO offerings to watch out for.
Big Tech Is Taking on Diabetes https://www.fool.com/investing/2017/04/24/big-tech-is-taking-on-diabetes.aspx?source=iedfolrf0000001 Apr 24, 2017 - The combination of big tech and healthcare may be an unlikely matchup, but as these collaborations become more prevalent, patients will be the ultimate beneficiaries.

Pages: 1...8182838485868788899091...94

<<<Page 86>